Results 211 to 220 of about 32,201 (250)

Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica. [PDF]

Acta Neuropathol Commun
Given KS, Acker EG, Macklin WB, Carlin D, Owens GP, Bennett JL.   +5 more
europepmc   +1 more source

Neuromyelitis optica spectrum disorders with recurrent syncope due to area postrema syndrome: a case report and literature review. [PDF]

BMC Neurol
Yin H, Wang Y, Xu Y.
europepmc   +1 more source

Neuromyelitis Optica Spectrum Disorder Presenting With Organizing Pneumonia: A Case Report and Literature Review. [PDF]

Cureus
Takeuchi Y, Masuda T, Otsuka M, Takeda A, Kimura N.   +4 more
europepmc   +1 more source

Pediatric-Onset Neuromyelitis Optica Spectrum Disorder in Isfahan: Insights from a Cross-Sectional Study. [PDF]

Iran J Child Neurol
Etemadifar M, Salari M, Norouzi M.
europepmc   +1 more source

Evaluation of CD3+CD56+ NKT and CD19+ B Cells in Assessing the Relapse of Neuromyelitis Optica Spectrum Disorder Patients Treated With Rituximab. [PDF]

Brain Behav
Zeng J, Zou M, Min M, Xu M.
europepmc   +1 more source

Decoding paraneoplastic neuromyelitis optica: a multi-omics investigation of tumor-driven T and B cell dynamics. [PDF]

Front Immunol
Huang W, Lin R, Zeng X, Wang H, Yan J.
europepmc   +1 more source

Corrigendum: C16 peptide promotes vascular growth and reduces inflammation in a neuromyelitis optica model. [PDF]

Front Pharmacol
Chen H, Fu X, Jiang J, Han S.
europepmc   +1 more source